www.popsci.com
Open in
urlscan Pro
151.101.129.91
Public Scan
URL:
https://www.popsci.com/science/moderna-launches-hiv-vaccine-clinical-trial/
Submission: On February 09 via api from US — Scanned from DE
Submission: On February 09 via api from US — Scanned from DE
Form analysis
1 forms found in the DOMGET https://www.popsci.com
<form class="navbar-form form-inline" action="https://www.popsci.com" method="GET">
<div class="bgr-mobile">
<input class="search__form-input search-form__text-input js-search-input" type="text" placeholder="Search by keyword…" name="s" value="">
</div>
<button aria-label="Search" type="submit" class="search-form__submit fa fa-search" value=""></button>
<button class="search-form__open fas fa-search js-toggle float-right"></button>
</form>
Text Content
* Science * Tech * DIY * Reviews * Subscriber Login Newsletter Sign-up * HOT TOPICS * Science * Technology * DIY * Reviews * Health * Animals * Space * Environment * Gadgets * Goods * EXPLORE * Subscriber Login * Newsletters * Podcasts * Video * Merch * PopSci Shop * FIND US ON * Facebook * Twitter * LinkedIn * Instagram * Pinterest * Youtube * Flipboard * Apple News+ * RSS SOCIAL THE FIRST PEOPLE HAVE RECEIVED AN EXPERIMENTAL MRNA HIV VACCINE Moderna is hoping its mRNA technology will succeed where other HIV vaccines failed. By Hannah Seo | Published Feb 2, 2022 12:00 PM * Science * Health Moderna's clinical trials are officially underway for the first HIV vaccine of its kind. Unsplash SHARE * * * * Moderna announced last week that it has begun dosing its first participants in Phase I clinical trials for an HIV vaccine that uses the same mRNA technology as the company’s COVID-19 vaccine. PLAY Top Articles by Popular Science Video Settings Full Screen About Connatix V149379 Read More Read More Read More Read More Read More Read More A Black Hawk helicopter flew for the first timewithout pilots 1/1 SkipAd Continue watching after the ad Visit Advertiser websiteGO TO PAGE The company, which is conducting the trial in partnership with the nonprofit International AIDS Vaccine Initiative (IAVI), hopes the trial will confirm whether the vaccine can deliver HIV-specific antigens to the body and induce an immune response. Researchers will study 56 HIV-negative adults for six months. Forty-eight of the volunteers will receive at least one dose of the primary vaccine, 32 of whom will also receive the booster. The remaining eight will receive the booster vaccine alone. The first participants were just vaccinated at George Washington University School of Medicine and Health Sciences in Washington, D.C. With mRNA-based vaccines, such as the one being tested, mRNA strands enter human cells and take our immune systems on a test run. This gives immune cells a heads up for what they can expect if they encounter a virus. This process works incredibly well against SARS-CoV-2, and so there’s hope that it may be protective against HIV as well. [Related: For the second time ever, someone was spontaneously cured of HIV] “We are tremendously excited to be advancing this new direction in HIV vaccine design with Moderna’s mRNA platform,” Mark Feinberg, president and CEO of IAVI, said in a statement. “The search for an HIV vaccine has been long and challenging, and having new tools in terms of immunogens and platforms could be the key to making rapid progress toward an urgently needed, effective HIV vaccine.” Researchers have long sought a vaccine to protect against HIV. Various medications and treatments mean that HIV prognosis is often manageable, and no longer the death sentence it once was—but HIV is notoriously difficult to vaccinate against. The virus integrates itself into the human genome within 72 hours of transmission, producing an irreversible infection. Many previous attempts to create a vaccine have made it to the clinical trial phase, but later failed as they didn’t generate high enough protective antibodies at a fast enough rate to completely prevent infection. Hannah Seo Hannah is a freelance science journalist, podcast writer, and poet based in Brooklyn. In addition to Popular Science, her work can be found in WIRED, Scientific American, The Walrus, and Environmental Health News, among others. clinical trials HIV immune system moderna vaccine mRNA vaccine MORE TO READ * RELATED JUST HAD COVID? HERE’S WHEN YOU SHOULD GET A BOOSTER. The exact timing often won't make a big difference, but consider these questions. READ NOW * RELATED WHY YOUNG ORPHANS WERE ONCE USED AS HUMAN REFRIGERATORS Plus other fun facts from The Weirdest Thing I Learned This Week. * RELATED ALL YOUR BURNING QUESTIONS ABOUT SUSTAINABLE AVIATION FUEL, ANSWERED They promise to help the aviation sector move away from extracted petroleum products, but it's a complex topic. Like science, tech, and DIY projects? Sign up to receive Popular Science's emails and get the highlights. LET'S GO LINKS * Home * Newsletter Sign-up * Contact * Privacy Policy * Terms of Use * Masthead * Sitemap * DepositPhotos * Subscriber Login Cookies Settings FOLLOW US * * * * * DISCLAIMER(S) We are a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com and affiliated sites. Registration on or use of this site constitutes acceptance of our Terms of Service. © 2022 Recurrent. All rights reserved. PRIVACY PREFERENCE CENTER When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer. More information Allow All MANAGE CONSENT PREFERENCES PERFORMANCE COOKIES Performance Cookies These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. TARGETING COOKIES Targeting Cookies These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising. FUNCTIONAL COOKIES Functional Cookies These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly. STRICTLY NECESSARY COOKIES Always Active These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information. BACK BUTTON PERFORMANCE COOKIES Vendor Search Search Icon Filter Icon Clear checkbox label label Apply Cancel Consent Leg.Interest checkbox label label checkbox label label checkbox label label Confirm My Choices By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookies Settings Accept All Cookies ×